CME credits: 0.25

Valid until: 28-09-2019

Claim your CME credit at https://reachmd.com/programs/cme/precision-oncology-incorporating-next-generation-sequencing-ngs-nsclc/10412/

Non-small cell lung cancer (NSCLC) is a leading cause of cancer death in the United States. Identification of targetable mutations has led to the development of therapies and improvements in NSCLC patient outcomes. However, many patients continue to experience poor survival due to suboptimal genomic profiling and treatment. In this activity, we will evaluate the advantages of NGS testing platforms and companion diagnostics over the conventional genomic profiling approach and discuss strategies to overcome barriers to wide adoption in community oncology settings.

Dr. Joshua Bauml is joined by Dr. Timothy McCarthy to discuss incorporating NGS in NSCLC.